Interpreting feline leukemia test results

Area of Science:

• Veterinary Medicine
• Immunology
• Epidemiology

Background:

• Feline leukemia virus (FeLV) is a significant pathogen in domestic cats.
• Prevaccinal screening for FeLV is common practice in veterinary medicine.
• The low prevalence of FeLV viremia in the general cat population presents statistical challenges for screening tests.

Purpose of the Study:

• To evaluate the statistical limitations of routine prevaccinal screening for FeLV.
• To assess the impact of low FeLV prevalence on the accuracy of screening tests, specifically ELISA.
• To determine the reliability of positive and negative screening results for FeLV.

Main Methods:

• Statistical analysis of screening test results in a low-prevalence feline population.
• Calculation of false-positive and false-negative rates for ELISA tests.
• Interpretation of diagnostic test performance metrics in the context of disease prevalence.

Main Results:

• Routine FeLV screening is prone to a high rate of false-positive results, estimated at approximately 72%.
• The low prevalence of FeLV significantly magnifies the impact of false-positive errors.
• Routine screening demonstrates a very low false-negative rate, with only about 1 in 1,000 tests likely to be false-negative.

Conclusions:

• Positive ELISA results for FeLV in routine screening should be interpreted with caution due to a high likelihood of being false positives.
• Despite limitations with false positives, routine FeLV screening is a reliable method for excluding the presence of FeLV viremia.
• The high negative predictive value makes routine screening an effective tool for ruling out FeLV infection.